Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer.
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM.
Maggadottir SM, et al. Among authors: juul hv.
Mol Ther. 2024 Jun 5;32(6):2021-2029. doi: 10.1016/j.ymthe.2024.04.009. Epub 2024 Apr 6.
Mol Ther. 2024.
PMID: 38582964
Free article.